Inclusion Criteria:  Male, aged ≥ 18 years Prostate cancer patients with a Briganti calculated risk of LN metastases of 5-20% without evidence of metastases on Prostate-Specific Membrane Antigen (PSMA) PET/CT requiring an ePLND in the standard treatment Scheduled for a (robot-assisted) laparoscopic radical prostatectomy Written informed consent  Exclusion Criteria:  American Society of Anaesthesiology (ASA) classification > 3 Patients with a contradiction for a lymphadenectomy Neoadjuvant hormone deprivation therapy Absence or withdrawal of an informed consent Evidence of metastases on pre-operative PSMA PET/CT